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Abstract 
Canine obesity is a serious breeding and health issue. Recent studies reported 
that 34-59% of dogs visiting veterinary are overweight and 5-20% are obese. 
Recent studies have shown that during the development of obesity there is several 
alterations at the cellular and molecular levels that contribute to the secretion of local 
and systemic molecules, called adipokines. These molecules contribute to the existence 
of a chronic low grade inflammatory state, to angiogenesis, to the control of appetite and 
satiety and to the control of the glucose and lipid metabolism. Together, these alterations 
may explain the reduced life span of obese animals and the development of several 
pathologies. 
One of main adipokines is leptin that plays a key role in the regulation of body 
weight, energy balance and feeding behaviour. Leptin is mainly regulated by adiposity, 
existing a positive correlation between the degree of adiposity and the plasma leptin 
concentration. In addition to adiposity, others factors regulate the leptin production such 
as insulin, glucocorticoids, endotoxin, and cytokines. 
Due to the contribution of leptin to the metabolism of glucose and lipids, several 
studies suggested that it may to establish an association between obesity, insulin 
resistance and ultimately diabetes. In fact, in humans the occurrence of obesity, 
dyslipidaemia and hypertension has been long associated to the development of insulin 
resistance and diabetes. However, the association between canine obesity and diabetes 
is not well understood, and there is no consensus whether obesity induces diabetes. 
Considering that obesity and diabetes reduce life span and the mechanisms 
underlying its development are not clearly understood, in this article we review the 
current knowledge on the association between obesity, diabetes and leptin. 
 
Keywords: Obesity; Diabetes mellitus; Leptin; Insulin resistance. 
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Resumo 
A obesidade canina é uma grave questão de bem-estar. Estudos recentes 
mostram que 34-59% dos cães que visitam o veterinário têm excesso de peso e 5-20% 
são considerados obesos. 
      Estudos recentes mostram que, durante o desenvolvimento da obesidade há 
várias alterações a nível celular e molecular que contribuem para a secreção de 
moléculas locais e sistémicas, chamadas adipocinas. Estas moléculas contribuem para 
a existência de um estado inflamatório crónico, para a angiogénese, para o controlo do 
apetite e saciedade e para o controlo do metabolismo da glucose e dos lípidos. Em 
conjunto, estas alterações podem explicar a redução do tempo de vida dos animais 
obesos e o desenvolvimento de várias patologias. 
      Uma das principais adipocinas é a leptina que desempenha um papel 
fundamental na regulação do peso corporal, balanço energético e comportamento 
alimentar. A leptina é regulada principalmente pela adiposidade, existindo uma 
correlação positiva entre o grau de adiposidade e a concentração de leptina no plasma. 
Além da adiposidade, outros factores regulam a produção de leptina, tais como a 
insulina, os glucocorticóides, endotoxinas e citoquinas. 
      Devido à contribuição da leptina para o metabolismo da glicose e dos lípidos, 
vários estudos sugerem que esta adipocina pode estabelecer uma associação entre 
obesidade, resistência à insulina e, finalmente, diabetes. De facto, nos humanos a 
ocorrência de obesidade, dislipidemia e hipertensão têm sido associados com o 
desenvolvimento de resistência à insulina e com a diabetes. No entanto, a associação 
entre a obesidade canina e diabetes não é bem compreendida, e não há consenso se a 
obesidade induz diabetes. 
Considerando que a obesidade e a diabetes reduzem o tempo de vida e os 
mecanismos subjacentes ao seu desenvolvimento não são claramente compreendidos, 
neste artigo vamos rever o conhecimento atual sobre a associação entre obesidade, 
diabetes e leptina. 
 
Palavras-chave: Obesidade; Diabetes mellitus; Leptina; Resistência à insulina. 
  
The role of leptin in obesity and diabetes mellitus in dog 
 
v 
 
Index 
1. Introduction 1 
2. Canine obesity 2 
3. Diabetes mellitus 
 
8 
4. Correlation between obesity, diabetes and leptin 
 
12 
5. Conclusion 
 
17 
6. Appendix 
 
18 
7. Acknowledgements 
 
19 
8. References 
 
20 
  
 
 
 
 
 
 
 
 
 
 
The role of leptin in obesity and diabetes mellitus in dog 
 
vi 
 
Figures Index 
Figure 1- Adipose tissue and adipokines  
Figure 2- Molecular and cellular alterations associated to obesity  
 
 
 
 
 
 
 
Tables Index 
Table 1 - Body condition score based on 9 categories 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The role of leptin in obesity and diabetes mellitus in dog 
 
vii 
 
List of abbreviations 
 
BCS    Body condition score 
BMI    Body max índex 
DM    Diabetes mellitus 
IL-1    Interleukin-1 
IL-1RA   Interleukin-1 receptor antagonist 
IL-6    Interleukin-6 
PI3K    Phosphatidylinositol-3-kinase 
PPARƔ   Peroxisome-proliferator 
TGFβ    Transforming growth factor β 
TNFα    Tumor necrosis factor α 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The role of leptin in obesity and diabetes mellitus in dog 
 
1 
 
1. Introduction 
Canine obesity is a growing problem that results from accumulation of body fat 
due to a mismatch between energy intake and energy expenditure. It is not possible to 
determine the exact prevalence of obesity due to the lack of an accurate method to 
measure adiposity but it is considered that it ranges from 5% to 20%, in several countries 
(Courcier et al.,2010; Switonski & Mankowska, 2013). 
Obesity has negative effects on health, leading to reduced life expectancy and/or 
increased health problems such as dyslipidaemia, arthritis, intolerance to exercise, 
tracheal collapse, hyperadrenocorticism, hypoventilation, heat intolerance and increased 
risk to develop diabetes mellitus (DM) (German et al., 2010; Zoran, 2010). Among dogs 
the relationship between obesity and DM is not clearly understood but it is generally 
accepted that omental fat induces insulin resistance and also that obesity contributes to 
hypertension and to the alteration of lipid profile, alterations that improve with weight loss 
(Tvarijonaviciute et al., 2012; German et al., 2010; German 2006). 
Considering the increased prevalence of obesity and its negative consequences 
to the dog’s quality of life it is important to establish preventive attitudes and to implement 
the adequate therapeutic measures. For that, it is important to understand the 
mechanisms underlying the development of obesity and the molecular and cellular 
alterations associated to the increased adiposity.  
There are several factors associated to obesity such as age, sex, breed, 
neutering, endocrinopathies such as hypothyroidism and hyperadrenocorticism, feeding, 
sedentary lifestyle, and behavioural factors (Colliard et al.,2006; Courcier et al., 2010; 
Diez et al., 2006; German, 2006). Some of these factors could be avoid if the owners 
adopt healthy habits, but other factors are intrinsic to the dogs. In these last situations it 
is important to understand the characteristics of the adipose tissue. 
Recent studies showed that adipose tissue produce several active molecules 
such as chemokines, pro-inflammatory mediators such as tumour necrosis factor alpha, 
interleukin-1 (IL-1), interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6) and 
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transforming growth factor β (TGFβ), and hormone-like molecules such as leptin (Kwon 
& Pessin 2013; Cammisotto & Bendayan 2007; Griffin & Guilak 2009; Balistreri et al. 
2010; Tvarijonaviciute et al. 2012).  
Leptin is a small non-glycosylated peptide of 146 amino acids and of 16 kDa. 
Once produced, leptin mainly reduces appetite and regulates the metabolism of 
carbohydrates and lipids (Iwase et al. 2000; Ishioka et al. 2005; Ishioka et al. 2007; 
Ishioka et al. 2002).  
Recent studies pointed to a loss of the leptin function in obese dogs that may 
worsen the obesity. Since obesity is associated to the impaired glucose metabolism and 
to the development of insulin resistance it is possible that the impaired effect of leptin in 
obesity contributes to the worsening of insulin resistance and ultimately for the 
development of DM. However, the association between obesity, leptin and diabetes is 
unclear and consequently it is difficult to establish therapeutic targets in order to treat 
obesity and DM. 
 
2. Canine Obesity 
Canine obesity is a serious breeding and health issue that among other 
consequences is associated to a decrease in dogs life span, orthopaedic problems,  
development of DM, and to an increased risk to the development of tumours (German et 
al., 2010). Recent studies reported that 34-59% of dogs visiting veterinary are overweight 
and 5-20% were considered obese (Switonski & Mankowska, 2013). Taking in 
consideration the incidence of obesity and the fact that this clinical condition has several 
health and wellness implications for pets and their owners (Corbee, 2012) it is important 
to understand the pathophysiology and the risk factors associated to it, in order to 
implement the adequate treatment and to establish preventive measure (Zoran, 2010). 
Obesity occurs when for an extended period of time, animals have an excessive 
dietary intake or inadequate energy usage that induce a positive energy balance 
(Courcier et al., 2010). This situation will induce an abnormal or excessive fat 
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accumulation and consequently the development of adiposity whose quantification will 
establish the degree of obesity. However, among companion animals it is difficult to 
establish an accurate protocol to quantify the adiposity and there is no consensus on the 
best method (Ishioka et al., 2007). 
Some authors have considered overweight when the dog’s weight is 10 to 20% 
higher of the ideal weight and obesity when dog’s weight is 20% higher of the ideal weight 
(Ishioka et al., 2002; Rand et al.,2004).  However, this criteria was dependent on the 
definition of “optimal body weight” for each breed which is not defined (German, 2006). 
Nonetheless, the body weight is still a valuable tool whilst dogs are on a diet since it 
allows a control of the weight loss. Others clinicians tried to applied the body mass index 
(BMI), generally used to diagnose obesity in humans, but due to the morphological and 
anatomical peculiarities of each breed, this index did not give objective data in small 
animal clinic (Ishioka et al., 2002). 
In order to overwhelm these difficulties, clinicians started to evaluate body 
condition using a score based on visual assessment and palpation of several parameters 
such as bony prominences evidence, muscle mass and presence of fat (Switonski & 
Mankowska, 2013). Three main body condition scoring (BCS) exist, all of which use 
similar visual and palpable characteristics, but differ by the number of categories within 
the scoring system (e.g., 5 points, 6 points, and 9 points) (German, 2006). The most 
widely accepted system is the 9 points BCS, since it was demonstrated that it correlates 
better with body fat mass determined by dual-energy X-ray absorptiometry (German, 
2006).  According to this nine points BCS, dogs classified with 1 are emaciated animals 
and dogs classified with 9 are considered grossly obese, table 1. Dogs classified with 4-
5 points are considered as having an adequate body condition.  
In spite of the efforts, the application of the 9 points BCS is still dependent on the 
experience and subjectivity of the clinician (Ishioka et al., 2002).  Most of the clinicians 
considered that dog has ideal weight when the ribs are easily palpable, waist is easily 
noted and abdominal tuck is evident.  
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The lack of a quantitative method for determining overweight and obesity 
complicates the analysis of the results obtained in epidemiological studies of canine 
obesity and the identification of risk factors. 
  
Table 1. Body condition score based on 9 categories. 
 
 
Body 
condition 
Score Overall body appearance 
Too thin 1 Ribs, lumbar vertebrae, pelvic bones and all bony prominences evident from 
a distance. No discernible body fat. Obvious loss of muscle mass. 
Too thin 2 Ribs, lumbar vertebrae and pelvic bones easily visible.  
No palpable fat. Some evidence of other bony prominence.  
Minimal loss of muscle mass. 
Too thin 3 Ribs easily palpated and may be visible with no palpable fat.  
Tops of lumbar vertebrae visible. Pelvic bones becoming prominent. 
Obvious waist and abdominal tuck. 
Ideal 4 Ribs easily palpable, with minimal fat covering. Waist easily noted, viewed 
from above. Abdominal tuck evident. 
Ideal 5 Ribs palpable without excess fat covering. Waist observed behind ribs when 
viewed from above. Abdomen tucked up when viewed from side. 
Too heavy 6 Ribs palpable with slight excess fat covering. Waist is discernible viewed 
from above but is not prominent. Abdominal tuck apparent. 
Too heavy 7 Ribs palpable with difficulty; heavy fat cover. Noticeable fat deposits over 
lumbar area and base of tail. Waist absent or barely visible. Abdominal tuck 
may be present. 
Too heavy 8 Ribs not palpable under very heavy fat cover, or palpable only with 
significant pressure. Heavy fat deposits over lumbar area and base of tail. 
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Obesity is usually associated to dietary factors and consequently to energy 
imbalance, too many calories consumed or too few calories burned. Nonetheless, it is 
accepted that obesity is multifactorial and is also dependent on factors such as age, 
breed, sex, gonadal status and hormonal influences, occurrence of endocrinopathies, 
sedentary lifestyle, and behavioural factors (Zoran, 2010).  
It is considered that the incidence of obesity increases with the age of both the 
dog and the owner (Courcier et al., 2010; Diez et al., 2006). In a study performed by 
Courcier et al. in the UK,  39.9% of the obese dogs were between three and eight years 
old and  38.6% were nine years or older which is in agreement with other studies (Diez 
et al. 2006; Lund et al.2006; Colliard et al. 2006). The predisposition to obesity of older 
animals seems to be associated to the reduction in the metabolic rate and to a reduced 
physical activity (Zoran 2010; Lund et al.2006; Colliard et al. 2006). 
Considering the breed predisposition, previous studies showed that certain 
breeds including Cairn Terriers, West Highland White Terriers, Scottish Terriers, 
Shetland Sheepdogs, Basset Hounds, Cavalier King Charles Spaniels, Dachshunds, 
Beagles, Cocker Spaniels, and Labrador Retrievers had an increased predisposition to 
develop obesity (Diez et al., 2006; Edney & PM, 1986). Conversely, certain breeds, 
particularly Greyhounds and various Sheep Herding breeds appear to be resistant to the 
development of obesity (Zoran, 2010).  However, recently in a study performed in the 
UK, Courcier et al. reported that it was not found a statistical association between breed 
and obesity (Courcier et al., 2010). Moreover, Courcier et al. also suggested that the 
Waist absent. No abdominal tuck. Obvious abdominal distention may be 
present. 
Too heavy 9 Massive fat deposits over thorax, spine and base of tail.  
Waist and abdominal tuck absent. Fat deposits on neck and limbs. Obvious 
abdominal distention. 
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previous association was due to the existence of confounders factors such as the 
environmental factors (Courcier et al., 2010).  
Another clear risk factor for obesity is gender and neutering. Previous studies 
reported that obesity is more prevalent in females than in males (Lund et al. 2006; Diez 
et al. 2006; Colliard et al. 2006; Courcier et al. 2010). In addition to gender, neutering is 
also considered a risk factor to the development of obesity, being the incidence of obesity 
higher in neutered dogs of both sexes (Colliard et al., 2006; Courcier et al., 2010; Diez 
et al., 2006; German, 2006; Lund et al., 2006). In a study performed across United 
States, 38% of all castrated male and spayed female adult dogs were overweight or 
obese. This problem is believed to be due to hormonal changes associated with 
neutering that change the feeding behaviour, contribute to reduction of the metabolic rate 
and to a reduction in physical activity. Recent studies also showed that the loss of sex 
hormones induce alterations in the brain centres that affect satiety, metabolism and the 
production of hormonal regulators of food intake such as leptin (Zoran, 2010).  
In addition to these causes, there are others factors that may contribute to the 
development of obesity like the lifestyle, human-animal relationship and behavioural 
factors like anxiety, depression, failure to establish a normal feeding behaviour, and 
failure to develop control of satiety (German, 2006). However, the contribution of these 
factors to obesity is dependent on several variables (owner’s age and lifestyle, existence 
of several animals at the same place, time that the animal spent alone) that limit the 
evaluation of its contribution per si for the development of obesity. 
Independently of the subjacent cause of obesity, it is considered that obese dogs 
have a significant reduction in mean life span and require medication for chronic health 
problems sooner than non-obese dogs (Kealy et al., 2002). In fact, the deposition of 
adiposity is associated to the occurrence of cardiovascular diseases, respiratory 
difficulties and osteoarticular problems (German et al., 2010). The adiposity increases 
the circulating blood volume and the cardiac output in order to irrigate the excess of 
adipose tissue (Waltham, 1999).This increase in workload together with the fact that in 
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obese dogs there is also deposition of fatty in heart that will contribute to the reduction 
of cardiovascular reserves and to the development of congestive heart problems 
(Laflamme, 2012). In addition, the deposition of fat around airways of laryngeal and 
pharyngeal areas may exert pressure and lead to a narrowing of the airways, contributing 
to respiratory insufficiency and to exercise intolerance (Waltham, 1999). Obesity also 
increases biomechanical loading contributing to the development of osteoarthritis, which 
in turns leads to reduced mobility and to a reduction in energy expenditure worsening 
the obesity (Griffin & Guilak 2009; Laflamme 2012). 
 Although early studies indicate that the effect of obesity was mainly due to fat 
deposition in different organs, recent studies have shown that there were also several 
alterations at the cellular and molecular level (Laflamme,2012; Tvarijonaviciute et al. 
2012). During the development of obesity, cells become overload with fatty acids that 
will contribute to hypertrophy and hyperplasia of adipocytes. This cellular stress induces 
the secretion of local and systemic molecules called adipokines, including more than 50 
cytokines, chemokines, hormone-like factors such as leptin and adiponectin and pro-
inflammatory mediators such as tumour necrosis factor alpha (TNFα), interleukin-1 (IL-
1), interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6) and transforming 
growth factor β (TGFβ), figure 1 (Balistreri et al., 2010; Cammisotto & Bendayan, 2007; 
Griffin & Guilak, 2009; Kwon & Pessin, 2013; Tvarijonaviciute et al., 2012). Together, 
these mediators contribute to the existence of a chronic low grade inflammatory state, to 
angiogenesis, alter the control of appetite and satiety and control the glucose and lipid 
metabolism, which may explain the reduced life span of obese animals. (Laflamme, 
2012; Kwon & Pessin 2013; Balistreri et al. 2010). 
 
 
 
The role of leptin in obesity and diabetes mellitus in dog 
 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Adipose tissue and the production of adipokines. 
 
 
3. Diabetes mellitus 
 Diabetes mellitus (DM) is one of the most frequently diagnosed endocrinopathies 
among dogs that is characterised by a chronic excess of blood glucose, resulting from 
defects in impaired insulin secretion, impaired insulin action, or both (Fall, 2009; Rand et 
al., 2004). 
 In companion animals, like in humans, two types of DM are recognized.(Rand et 
al., 2004). Among cats it is considered that 80-95% of diabetic present clinical 
characteristics and histological findings similar to the DM type 2 in humans. This type of 
diabetes is characterized by abnormal insulin secretion and peripheral insulin resistance, 
Adipose Tissue 
Leptin 
Adiponectin 
Resistin 
Visfatin 
IL-6 TNF α 
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being obesity and physical inactivity major risk factors for its development. (Fall, 2009; 
Hoenig, 2014; Rand et al., 2004).  
On the other hand, dogs usually suffer from DM that resembles human DM type 
1 which is characterized by an impaired insulin production.  The stimulation of beta cells 
by glucose, it is not accompanied by an increase in the insulin releasing, suggesting that 
there is a decrease of beta cells or that beta cells became unresponsive (Hoenig, 2002). 
One of the main causes of diabetes in dogs is chronic pancreatitis associated to auto-
immune diseases that induces an extensive pancreatic damage and consequently an 
impaired insulin production.  Another cause of DM among dogs is age which is 
associated to a decline in beta cell function. In fact, DM rarely occurs in dogs younger 
than one year of age but affects 70 % of dogs older than seven at the time of diagnosis 
( Hoenig, 2002). However, it is also important to consider that dogs may also develop a 
diabetes that resembles a human type 2 diabetes, associated to peripheral insulin 
resistance induced by others endocrinopathies such as Cushing disease and 
acromegaly, or by the long-term use of steroid drugs (Kahn et al., 2006).  
In addition to pancreatitis and age it is also considered that breed, and sex may 
also contribute to the development of diabetes among dogs.  In fact, there are several 
breeds that present an increased risk to the development of diabetes such as 
Keeshonds, Pulis, Cairn Terriers, Miniature Pinschers, Poodles, Samoyeds, Australian 
Terriers, Schnauzers, Spitz, Fox Terriers, Bichon Frise, and Siberian Huskies.  In 
females, it is considered that insulin resistance may accompany the heat cycle and 
gestational diabetes may occur during pregnancy (Zoran, 2010). 
More recently, obesity has also been associated to the development of insulin 
resistance and also to DM. However, the association between canine obesity and 
diabetes is not well understood (Ellmerer et al. 2006; German 2006; German et al. 2010, 
Laflamme, 2012). Among humans, it is considered that central obesity may contribute to 
the development of glucose intolerance and posteriorly to the development of diabetes 
type 2.  Nevertheless, in veterinary medicine the link between obesity and diabetes it is 
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not well established. In cats, it is known that insulin sensitivity decreases by about 30 % 
for each kilogram of body weight gain (German, 2006;Hoenig et al.,2007; Rand et al., 
2004;Laflamme,2012) and feline obesity is associated with up to an 4-fold increased risk 
for development of DM (Laflamme, 2012,Lund et al. 2006). 
Among dogs, it is considered that omental fat induces insulin resistance and also 
that obesity contributes to hypertension and to the alteration of lipid profile, alterations 
that ameliorated by weight loss (German et al., 2010; German, 2006; Tvarijonaviciute et 
al., 2012). Nonetheless, the molecular mechanisms that correlate obesity with insulin 
resistance and diabetes are not well understood ( Hoenig et al., 2007) 
 According previous studies, there are two theories that may explain this 
correlation (Bergman et al., 2007). One of the theories is based on the fact that visceral 
fat release non-esterified fatty acids that accumulate in the pancreatic beta cells inducing 
deterioration of β-cell function and reducing the production of insulin (Bergman et al., 
2007).  
The other theory is based on the ability of  adipocytes to produce adipokines such 
as IL-1, IL-6, TGFβ, leptin, resistin, visfatin and adiponectin that may induce an 
inflammatory state and reduce insulin sensitivity of liver and muscle cells, figure 1 and 2 
(Kwon & Pessin 2013; Cammisotto & Bendayan 2007; Griffin & Guilak 2009; Balistreri et 
al. 2010; Tvarijonaviciute et al. 2012; German et al. 2010, Laflamme, 2012). 
The insulin resistance seems to be associated with the inhibition of glucose 
oxidation by the non-esterified fatty acids. The impaired glucose metabolism could be 
explained by two different pathways that may occur simultaneously. On the one hand, 
the intracellular beta oxidation of fatty acids generates a great amount of acetil-
coenzyme A that inhibits the phosphofructokinase and hexokinase activity and 
subsequently the use of glucose (Kahn et al., 2006). On the other hand, the increase in 
the intracellular content of fatty acid metabolites such as diacylglycerol, fatty acyl-
coenzyme A, and ceramides may activate a serine/threonine kinase cascade leading to 
serine/threonine phosphorylation of insulin receptor substrate and consequently to a 
The role of leptin in obesity and diabetes mellitus in dog 
 
11 
 
decreased in the activity of  PI3K/AKT (Kahn et al., 2006).  The PI3K/AKT is the signalling 
pathway that facilitates glucose uptake in adipocytes and muscle cells by allowing the 
translocation of glucose transporters to the plasma membrane, figure 2 (Kahn et al., 
2006; Vargas et al., 2004). Therefore, a reduction in the activation of this signalling 
pathway will induce impaired glucose uptake and will generate insulin resistance 
(Hoenig, 2002). 
In addition to the production of adipokines and to the metabolic alterations, recent 
studies reported that obesity also alters the expression of several genes involved in 
glucose and lipid metabolism. One of these genes is the peroxisome-proliferator 
activated receptor γ (PPAR γ) which encoded the protein with the same name. PPAR γ 
seems to contribute to increase insulin sensitivity in muscle and adipose tissue due to its 
ability to regulate the transcription of other genes. However, Gayet et al. reported that in 
obese dogs there is a decrease in PPAR γ mRNA expression.  Furthermore, since the 
target genes of PPAR γ encode proteins involved in the release and storage of fatty 
acids, such as leptin, and adiponectin and of proteins directly involved in glucose uptake 
such as the insulin-dependent glucose transporter GLUT4, several studies pointed that  
PPAR γ contributes to the insulin resistance developed in obese dogs, figure 2 (Gayet 
et al.,2007; Kintscher & Law, 2005; Leonardini et al.,2009) 
 Considering the hypothesis that obesity contributes to the development of 
insulin resistance and also that obesity is a serious problem among dogs, it is expecting 
that the percentage of dogs developing diabetes type 2 will increase in the next years. 
Therefore, it is important to implement preventive measures to avoid obesity and to 
investigate the role of adipokines such as leptin produced by adipose tissue. 
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Figure 2. Molecular and cellular alterations associated to obesity 
 
4. Correlation between obesity, diabetes and leptin 
As previously referred adipose tissue produces adipokines  that influence various 
biologic processes including energy balance, glucose and lipid metabolism, 
inflammation, immune function, haemostasis, vascular function and angiogenesis,  figure 
1 and 2 (Zoran 2010; German et al. 2010; Kwon & Pessin 2013; Cammisotto & Bendayan 
2007; Griffin & Guilak 2009; Balistreri et al. 2010; Tvarijonaviciute et al. 2012; Laflamme, 
2012). 
One of the main adipokines is leptin, the ob (obese) gene product that plays a 
key role in the regulation of body weight, energy balance and feeding behaviour (Ishioka 
et al., 2005, Ishioka et al.,2007; Ishioka et al., 2002; Iwase et al., 2000).  In dogs, this 
adipokine is synthesized and secreted mainly by adipocytes but in humans and mice it 
is also produced by gastric epithelial cells, placenta, mammary gland and liver 
(Cammisotto & Bendayan, 2007; Zoran, 2010). Structurally, leptin is a small non-
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glycosylated peptide of 146 amino acids and of 16 kDa discovered in 1994 by Zhang et 
al (Cammisotto & Bendayan, 2007; Zhang et al., 1994). 
The production of leptin is mainly regulated by adiposity, existing a positive 
correlation between degree of adiposity and plasma leptin concentration observable in 
several species, including dogs. In addition to adiposity, other factors also regulate the 
leptin production such as insulin, glucocorticoids, endotoxin, and cytokines (TNFα, IL1b, 
and IL-6) (Zoran, 2010). 
 According the feeding-fasting cycles and to the net effects of various 
neuroendocrine and nutritional factors such as glucose, insulin, glucocorticoids and 
catecholamines, serum leptin concentration shows diurnal changes. More specifically, 
plasma leptin rises immediately following food intake, shows a peak 5-8 hours afterwards 
and then slowly decreases to basal levels 19-23 hours after a meal. In contrast when 
dogs are fasted, plasma leptin levels gradually decrease to levels even lower than basal 
values and then return to baseline limits within 12 hours of re-feeding (Ishioka et al., 
2005; Ricci & Bevilacqua, 2012). 
In spite of the diurnal variations, Ishioka et al. demonstrated that among dogs the 
plasma leptin concentration was independent of age, sex and of reproductive status 
(neutered or intact) regardless they were obese or of optimal body condition (Ishioka et 
al., 2007; Ishioka et al., 2002). 
 Once produced leptin reduces appetite and regulates the cellular metabolism 
(stimulates lipolysis, inhibits lipogenesis, improves insulin sensitivity, increases glucose 
metabolism and stimulates fatty acid oxidation). In addition, recent studies reported that 
leptin also contributes to the proliferation of lymphocytes (particularly CD4+) and to the 
induction of Th1 response, cytokine production, phagocytosis, regulation of 
hypothalamic-pituitary-adrenal-axis, reproduction, angiogenesis, and oxidative stress 
(Balistreri et al., 2010; Cammisotto & Bendayan, 2007; Nishii et al., 2010).  
The effects of leptin are initiated through interaction with its receptor. The leptin 
receptor present six isoforms, belongs to the family of the gp130 receptors and is closely 
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related to members of the IL-6 family of receptors. Five of the receptors are membrane 
bound and the sixth is a soluble form that binds leptin in circulation to enhance its half-
life (Cammisotto & Bendayan, 2007). The highest numbers of receptors are expressed 
at the satiety centres of the hypothalamus, but they can be found widely distributed 
throughout the body, reflecting leptin’s involvement in the regulation of several 
physiologic processes (Ricci & Bevilacqua, 2012). 
Binding of leptin to its receptor in the hypothalamus activates a signalling pathway 
that reduces appetite, through the stimulation of anorexigenic neurons, suppression of 
orexigenic neurons, and suppression of the release of endocannabinoids, which are 
regulators of orexigenic neurons (Amitani et al.,2013; Marroquí et al., 2012). These 
properties of leptin were evidenced by several studies and explain the reason why leptin 
is one of the main adypokine implicated in obesity. 
Previous studies performed in mice showed that mutation of the DNA sequence 
encoding leptin was associated with the development of hyperphagia and morbid obesity 
(Ricci & Bevilacqua, 2012) . Conversely leptin administration in obese mice resulted in 
reduction of food intake and weight loss (Ricci & Bevilacqua, 2012).  
Furthermore, it was showed that after a fatty or high-energy meal dogs present a 
2- to 3-fold increase in the leptin concentrations which was maintained for as long as 8 
hours, which confirms that leptin is associated to fatty acids and glucose metabolism 
(Ishioka 2005). This increased in leptin concentration was also confirmed in obese dogs 
from either experimentally induced obesity or pet dogs with increased body condition 
scores. In contrast, reduction in fat mass was accompanied by a decrease in leptin 
concentration (Ricci & Bevilacqua, 2012). 
 These results pose a question, if leptin controls food intake, and the plasma 
concentration of leptin in obese animals is increased as compared to non-obese how to 
explain the increase in obesity. A possibility to explain this contradiction was the 
occurrence of a mutation on the leptin receptor, turning cells resistant to the plasma 
leptin. However, several studies performed in humans reported that the majority of obese 
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humans do not present mutations at the leptin receptor and as far as we know there is 
no report of leptin receptor mutations in dogs (Dincer et al., 2005; Farooqi et al., 2007; 
Zoran, 2010). 
The other possibility is the development of leptin resistance as a result of the 
increased fat tissue. Leptin crosses the blood-brain barrier via a transport system that 
becomes saturated with the increased plasma concentration of leptin (Zoran 2010; 
Amitani et al. 2013, Marioqui). This hypothesis was evidenced in rodents studies where 
obesity has been associated with a state of leptin resistance mainly due to the inability 
of leptin to reach is target sites in the brain and/or to the reduction of the intracellular 
leptin receptor signalling cascade (Ricci & Bevilacqua, 2012). Although no studies have 
evaluated leptin resistance in dogs, it is fair to speculate that this condition also occurs 
in dogs (Ricci & Bevilacqua, 2012).   
 Considering these results, we may hypothesise that the impaired effect of leptin 
will contribute to the dysregulation of the appetite and of the lipid metabolism and 
therefore it will also contribute to the alteration of the glucose metabolism and to the 
development of insulin resistance. Moreover, recent studies performed in mice reported 
that leptin regulates not only glucose metabolism through its effects on body weight and 
food intake but also by independently pathway (Amitani et al., 2013; Denroche et al., 
2012; Kwon & Pessin, 2013; Zoran, 2010).  
 These effects of leptin seem to be mediated centrally via activation of specific 
neuronal subpopulations in the hypothalamus and through the activation of 
phosphatidylinositol-3-kinase (PI3K) signalling pathway which is also the pathway 
associated to the insulin signal transduction. As leptin exerts its effect upstream of PI3K, 
by the modulation of the phosphorylation satus of insulin receptor substrate-1 (Amitani 
et al., 2013; Denroche et al., 2012; Koch et al., 2010; Kwon & Pessin, 2013), it may 
override the need of insulin to regulate the glucose metabolism. Through this signalling 
pathway leptin has the ability to enhance hypothalamic sensitivity to insulin and to 
contribute to the homeostasis of glucose metabolism. 
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 Therefore, in obesity, the reduced ability of leptin to transverse blood-brain barrier 
has two main consequences: impairs the control of food intake and reduces the response 
of hypothalamus to insulin, dysregulating the glucose homeostasis (Amitani et al., 2013; 
Denroche et al., 2012; Koch et al., 2010; Kwon & Pessin, 2013; Zoran, 2010).  
 In addition to the effect of leptin at hypothalamus, it is also important to consider 
its effect at the pancreatic β-cells where leptin exerts two different actions:  inhibits insulin 
synthesis and secretion from β-cells; and controls β-cell proliferation, apoptosis, and cell 
growth (Amitani et al., 2013; Denroche et al., 2012; Koch et al., 2010; Kwon & Pessin, 
2013; Marroquí et al., 2012; Tomoaki, 2012; Zoran, 2010). 
The effect on insulin occurs in two different ways: leptin suppresses the 
expression of pre proinsulin mRNA in pancreatic β-cells and inhibits the signalling 
pathways involved in the transport of glucose and in the increased intracellular calcium 
concentration, both essentials to the secretion of insulin (Amitani et al., 2013; Marroquí 
et al., 2012; Tomoaki, 2012). 
This effect of leptin in pancreatic β-cells is part of a loop that controls the levels 
of plasmatic insulin and leptin (Amitani et al., 2013; Marroquí et al., 2012; Tomoaki, 
2012). These observations were obtained using animal models of obesity and therefore 
additional data will be necessary to clarify the function of leptin in dogs. Nevertheless, 
these consideration highlight the possible role of leptin in the control of obesity, glucose 
homeostasis and insulin resistance a triangle that needs to be better investigated among 
dogs in order to treat and prevent metabolic disorders. 
Among humans the first results regarding the plasma level of leptin in diabetic 
patients were controversial. Several studies reported that leptin levels were 
independently associated with DM after adjustment for BMI and total cholesterol 
(Bandaru & Shankar, 2011).  However, more recently Chen et al. reported that higher 
leptin levels were found to be associated with elevated risk of type 2 DM in men but not 
in women (Chen et al., 2014). 
In dogs, Nishii et al reported that obese diabetic dogs had lower plasma leptin 
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concentration than the body condition score-matched normal dogs but re-inforced that in 
diabetes other factors than adiposity may contribute to this reduced level (Nishii et al., 
2010). In fact, considering that obesity also contributes to the damage of β-cells reducing 
the insulin production and considering that the synthesis and storage of fat requires 
insulin, it is possible to hypothesize that from a certain point of diabetes there will be a 
persistent  hyperglycaemia and a progressive loss of body fat stores, similar to that 
observed in diabetes type 1, which will induce a reduction in the circulating levels of leptin 
(Morton & Schwartz, 2012).This hypothesis needs to be investigated in order to better 
understand the role of leptin in the pathophysiology of diabetes (Amitani et al., 2013; 
Denroche et al., 2012; Dincer et al., 2005).  
Independently on the controversy among the leptin plasma levels, studies 
performed in obese leptin deficient mice showed that the exogenous administration of 
leptin reduces obesity, restores insulin sensitivity and reverse hyperglycaemia which 
may indicate that leptin could be considered a potential therapeutic target (Amitani et al., 
2013; Denroche et al., 2012; Dincer et al., 2005; Koch et al., 2010). 
  
5. Conclusion 
 In   dogs, leptin is one of the first parameters that increase during weight gain, 
unlike plasma cholesterol, triglycerides, glucose and insulin, which do not change in the 
initial phase. This observation turns leptin as a valuable tool in the follow up of obesity 
and related disorders ( Ishioka et al., 2007). Since there is a direct correlation between 
adiposity and plasma level of leptin its monitorization during obesity- control programs 
may ensure fat loss instead of muscle loss. In addition, leptin could also be a helpful 
parameter in research to evaluate the effect of newly developed anti-obesity drugs 
(Ishioka et al., 2007; Ishioka et al., 2002). 
 Regarding the leptin role in diabetes, further studies are needed to clarify its 
contribution to the pathophysiology of this metabolic disease and its potential as a 
therapeutic target.  
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6. Appendix 
Classification of diabetes in dogs: 
a. Insulin deficiency diabetes includes beta cell loss hypoplasia or 
abiotrophy, exocrine pancreatic disease (such as pancreatitis), or 
idiopathic causes. 
b. Insulin resistant diabetes results from the insulin antagonistic effect of 
either endogenous or exogenous hormones, which oppose the effect of 
insulin and/or decrease insulin secretion such as sex steroids, 
glucocorticoids, and growth hormone, among others. (Hoenig, 2014) 
However, some cases don’t fit in this classification like gestational and dioestrous 
diabetes mellitus and for this reason a new classification system for canine diabetes 
mellitus was proposed. The following classes are proposed: juvenile, progesterone – 
related, secondary to pancreatic insult, endocrine tumours, iatrogenic, immune – 
mediated and idiopathic. (Fall, 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The role of leptin in obesity and diabetes mellitus in dog 
 
19 
 
7. Acknowledgements 
This dissertation would not have been possible without the help of so many 
people in so many ways. I am deeply grateful to my supervisors, Prof.  Anália do Carmo 
and Dr. Luís Barros, for patiently taking me through this difficult task and for their 
continuous encouragement and assistance. To Prof. Anália, I am grateful for the extra 
hours that she invested in this project, turning it into its final form, not only through her 
singular vision of reaching further, but also through her continuous assistance and 
inestimable guidance. To Dr. Luís Barros, the constant encouragement and ever 
available assistance complemented the fundamental support that was needed for me to 
achieve this challenge. 
Special thanks to Centro Veterinário Conimbricense, specially to Prof. Dr. Nuno 
Cardoso, Dr.ª Andreia Freire, Dr. Pedro Silva and Dr. Diogo Miraldo, for making me feel 
rather welcome amongst their team and the availability to answer my questions. 
I would, as well, like to register a collective recognition to all my colleagues and 
friends that have accompanied me along this path, for their most meaningful support, 
assistance and encouragement. 
Finally, I would like to avow a special acknowledgement to all my family, for their 
unconditional support; A very special deep gratitude to my mother Filomena, for her love 
and patient; To my father Eduardo, for his love and comprehension; To my sister 
Catarina, for her infinite support throughout everything; To my grandparents for being 
like a parents to me. 
Lastly, my absolute gratitude to my boyfriend, Mário Rui, for his patience, 
comprehension and untiring support. 
To all of them, thanks for always being there for me. 
 
 
 
 
The role of leptin in obesity and diabetes mellitus in dog 
 
20 
 
8. References 
Amitani, M., Asakawa, A., Amitani, H., & Inui, A. (2013). The role of leptin in the control 
of insulin-glucose axis. Frontiers in Neuroscience, 7(April), 51. 
doi:10.3389/fnins.2013.00051 
Balistreri, C. R., Caruso, C., & Candore, G. (2010). The role of adipose tissue and 
adipokines in obesity-related inflammatory diseases. Mediators of Inflammation, 
2010, 802078. doi:10.1155/2010/802078 
Bandaru, P., & Shankar, A. (2011). Association between plasma leptin levels and 
diabetes mellitus. Metabolic Syndrome and Related Disorders, 9(1), 19–23. 
doi:10.1089/met.2010.0037 
Bergman, R. N., Kim, S. P., Hsu, I. R., Catalano, K. J., Chiu, J. D., Kabir, M., … Ader, M. 
(2007). Abdominal obesity: role in the pathophysiology of metabolic disease and 
cardiovascular risk. The American Journal of Medicine, 120(2 Suppl 1), S3–8; 
discussion S29–32. doi:10.1016/j.amjmed.2006.11.012 
Cammisotto, P. G., & Bendayan, M. (2007). Leptin secretion by white adipose tissue and 
gastric mucosa. Histology and Histopathology, 22(2), 199–210. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/17149693 
Chen, G., Qin, L., & Ye, J. (2014). Leptin levels and risk of type 2 diabetes: gender-
specific meta-analysis. 
Colliard, L., Ancel, J., Benet, J., & Paragon, B. (2006). The WALTHAM International 
Nutritional Sciences Symposia, 1951–1954. 
Corbee, R. J. (2012). Obesity in show dogs. Journal of Animal Physiology and Animal 
Nutrition, 97, 904–910. doi:10.1111/j.1439-0396.2012.01336.x 
Courcier, E. a, Thomson, R. M., Mellor, D. J., & Yam, P. S. (2010). An epidemiological 
study of environmental factors associated with canine obesity. The Journal of Small 
Animal Practice, 51(7), 362–7. doi:10.1111/j.1748-5827.2010.00933.x 
Denroche, H. C., Huynh, F. K., & Kieffer, T. J. (2012). The role of leptin in glucose 
homeostasis. Journal of Diabetes Investigation, 3(2), 115–129. doi:10.1111/j.2040-
1124.2012.00203.x 
Diez, M., Ecvcn, D., & Nutrition, A. (2006). The epidemiology of canine, 16(1), 2–8. 
Dincer, D., Dick, G. M., Shibata, H., Knudson, J. D., Akahane, R., Saito, M., … Jarrod, 
D. (2005). Leptin resistance extends to the coronary vasculature in prediabetic dogs 
and provides a protective adaptation against endothelial dysfunction, 1393, 1038–
1046. doi:10.1152/ajpheart.00244.2005. 
Edney, A., & PM, S. (1986). Study of obesity in dogs visiting veterinary practices in the 
United Kingdom. The Veterinary Record, 118, 391. 
Ellmerer, M., Hamilton-Wessler, M., Kim, S. P., Huecking, K., Kirkman, E., Chiu, J., … 
Bergman, R. N. (2006). Reduced access to insulin-sensitive tissues in dogs with 
The role of leptin in obesity and diabetes mellitus in dog 
 
21 
 
obesity secondary to increased fat intake. Diabetes, 55(6), 1769–75. 
doi:10.2337/db05-1509 
Fall, T. (2009). Characterisation of Diabetes Mellitus in Dogs. 
Farooqi, I. S., Wangensteen, T., Collins, S., Kimber, W., Matarese, G., Keogh, J. M., … 
O’Rahilly, S. (2007). Clinical and molecular genetic spectrum of congenital 
deficiency of the leptin receptor. The New England Journal of Medicine, 356(3), 
237–47. doi:10.1056/NEJMoa063988 
Gayet, C., Leray, V., Saito, M., Siliart, B., & Nguyen, P. (2007). The effects of obesity-
associated insulin resistance on mRNA expression of peroxisome proliferator-
activated receptor-gamma target genes, in dogs. The British Journal of Nutrition, 
98(3), 497–503. doi:10.1017/S000711450772514X 
German, A. J. (2006). The WALTHAM International Nutritional Sciences Symposia The 
Growing Problem of Obesity in Dogs and Cats 1 – 3, 1940–1946. 
German, A. J., Ryan, V. H., German, A. C., Wood, I. S., & Trayhurn, P. (2010). Obesity, 
its associated disorders and the role of inflammatory adipokines in companion 
animals. Veterinary Journal (London, England : 1997), 185(1), 4–9. 
doi:10.1016/j.tvjl.2010.04.004 
Griffin, T. M., & Guilak, F. (2009). mouse models of obesity, 45(919), 387–398. 
Hoenig, M. (2002). Comparati v e aspects of diabetes mellitus in dogs and cats, 197, 
221–229. 
Hoenig, M. (2014). Carbohydrate metabolism and pathogenesis of diabetes mellitus in 
dogs and cats. Progress in molecular biology and translational science (1st ed., Vol. 
121, pp. 377–412). Elsevier Inc. doi:10.1016/B978-0-12-800101-1.00012-0 
Hoenig, M., Thomaseth, K., Waldron, M., & Ferguson, D. C. (2007). Insulin sensitivity , 
fat distribution , and adipocytokine response to different diets in lean and obese cats 
before and after weight loss, 30602, 227–234. doi:10.1152/ajpregu.00313.2006. 
Ishioka, K., Hatai, H., Komabayashi, K., Soliman, M. M., Shibata, H., Honjoh, T., … Saito, 
M. (2005). Diurnal variations of serum leptin in dogs: effects of fasting and re-
feeding. Veterinary Journal (London, England : 1997), 169(1), 85–90. 
doi:10.1016/j.tvjl.2004.01.003 
Ishioka, K., Hosoya, K., Kitagawa, H., Shibata, H., Honjoh, T., Kimura, K., & Saito, M. 
(2007). Plasma leptin concentration in dogs: effects of body condition score, age, 
gender and breeds. Research in Veterinary Science, 82(1), 11–5. 
doi:10.1016/j.rvsc.2006.06.002 
Ishioka, K., Soliman, M. M., Sagawa, M., Nakadomo, F., Shibata, H., Honjoh, T., … Saito, 
M. (2002). Experimental and clinical studies on plasma leptin in obese dogs. The 
Journal of Veterinary Medical Science / the Japanese Society of Veterinary 
Science, 64(4), 349–53. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12014581 
The role of leptin in obesity and diabetes mellitus in dog 
 
22 
 
Iwase, M., Kimura, K., Sasaki, N., Komagome, R., Ishioka, K., Morimatsu, M., … Saito, 
M. (2000). Canine leptin: cDNA cloning, expression and activity of recombinant 
protein. Research in Veterinary Science, 68(2), 109–14. 
doi:10.1053/rvsc.1999.0342 
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to 
insulin resistance and type 2 diabetes. Nature, 444(7121), 840–6. 
doi:10.1038/nature05482 
Kealy, R. D., Lawler, D. F., Ballam, J. M., Mantz, S. L., Biery, D. N., Greeley, E. H., … 
Stowe, H. D. (2002). Effects of diet restriction on life span and age-related changes 
in dogs. Journal of the American Veterinary Medical Association, 220(9), 1315–20. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11991408 
Kintscher, U., & Law, R. E. (2005). PPAR ␥ -mediated insulin sensitization : the 
importance of fat versus muscle, (33), 287–291. doi:10.1152/ajpendo.00440.2004. 
Koch, C., Augustine, R. a, Steger, J., Ganjam, G. K., Benzler, J., Pracht, C., … Tups, A. 
(2010). Leptin rapidly improves glucose homeostasis in obese mice by increasing 
hypothalamic insulin sensitivity. The Journal of Neuroscience : The Official Journal 
of the Society for Neuroscience, 30(48), 16180–7. doi:10.1523/JNEUROSCI.3202-
10.2010 
Kwon, H., & Pessin, J. E. (2013). Adipokines mediate inflammation and insulin 
resistance. Frontiers in Endocrinology, 4(June), 71. doi:10.3389/fendo.2013.00071 
Leonardini, A., Laviola, L., Perrini, S., Natalicchio, A., & Giorgino, F. (2009). Cross-Talk 
between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity. 
PPAR Research, 2009, 818945. doi:10.1155/2009/818945 
Lund, E. M., Armstrong, P. J., Kirk, C. A., & Klausner, J. S. (n.d.). Prevalence and Risk 
Factors for Obesity in Adult Dogs from Private US Veterinary Practices, 3–5. 
Marroquí, L., Gonzalez, A., Ñeco, P., Caballero-Garrido, E., Vieira, E., Ripoll, C., … 
Quesada, I. (2012). Role of leptin in the pancreatic β-cell: effects and signaling 
pathways. Journal of Molecular Endocrinology, 49(1), R9–17. doi:10.1530/JME-12-
0025 
Morton, G. J., & Schwartz, M. W. (2012). NIH Public Access, 91(2), 389–411. 
doi:10.1152/physrev.00007.2010.Leptin 
Nishii, N., Yamasaki, M., Takasu, M., Honjoh, T., Shibata, H., Otsuka, Y., … Kitagawa, 
H. (2010). Plasma leptin concentration in dogs with diabetes mellitus. The Journal 
of Veterinary Medical Science / the Japanese Society of Veterinary Science, 72(6), 
809–11. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20145380 
P, L. D. (2011). COMPANION ANIMALS SYMPOSIUM : Obesity in dogs and cats : What 
is wrong with being fat ? 1, 1653–1662. doi:10.2527/jas2011-4571 
Rand, J. S., Fleeman, L. M., Farrow, H. A., & Appleton, D. J. (2004). WALTHAM 
International Science Symposium : Nature , Nurture , and the Case for Nutrition 
Canine and Feline Diabetes Mellitus : Nature or Nurture ? 1, (10), 2072–2080. 
The role of leptin in obesity and diabetes mellitus in dog 
 
23 
 
Ricci, R., & Bevilacqua, F. (2012). The potential role of leptin and adiponectin in obesity: 
a comparative review. Veterinary Journal (London, England : 1997), 191(3), 292–8. 
doi:10.1016/j.tvjl.2011.04.009 
Switonski, M., & Mankowska, M. (2013). Dog obesity--the need for identifying 
predisposing genetic markers. Research in Veterinary Science, 95(3), 831–6. 
doi:10.1016/j.rvsc.2013.08.015 
The, F., Course, W., & Nutrition, C. (1999). Obesity in the Dog. 
Tomoaki, M. (2012). Enhanced GLP 1 and sulfanylurear induced insulin secretion in 
islets lacking leptin signaling. 
Tvarijonaviciute, A., Ceron, J. J., Holden, S. L., Cuthbertson, D. J., Biourge, V., Morris, 
P. J., & German, A. J. (2012). Obesity-related metabolic dysfunction in dogs: a 
comparison with human metabolic syndrome. BMC Veterinary Research, 8(1), 147. 
doi:10.1186/1746-6148-8-147 
Vargas, a M., Barros, R. P. a, Zampieri, R. a, Okamoto, M. M., de Carvalho Papa, P., & 
Machado, U. F. (2004). Abnormal subcellular distribution of GLUT4 protein in obese 
and insulin-treated diabetic female dogs. Brazilian Journal of Medical and Biological 
Research = Revista Brasileira de Pesquisas Médicas E Biológicas / Sociedade 
Brasileira de Biofísica ... [et Al.], 37(7), 1095–101. doi:/S0100-879X2004000700020 
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopod, L., & Friedman, J. (1994). 
Positional cloning of the mouse obese gene and its human homologue. 
Zoran, D. L. (2010). Obesity in dogs and cats: a metabolic and endocrine disorder. The 
Veterinary Clinics of North America. Small Animal Practice, 40(2), 221–39. 
doi:10.1016/j.cvsm.2009.10.009 
 
 
 
